
Transcript fusions have long been associated with cancer development. The recent use of comprehensive DNA/RNA sequencing in the cancer scenario has uncovered fusions that, today, are seen as optimal targets for personalized medicine, such as those involving genes ALK, FGFR and NTRK. The most frequent cancer driver fusions emerged from data cohorts such as TCGA consortium.
Like
Save
Share